Creative Planning’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$181K Sell
11,800
-959
-8% -$16K ﹤0.01% 3769
2025
Q4
$230K Buy
12,759
+425
+3% +$7.31K ﹤0.01% 3444
2025
Q3
$199K Sell
12,334
-630
-5% -$9.21K ﹤0.01% 3489
2025
Q2
$141K Buy
+12,964
New +$145K ﹤0.01% 3351
2025
Q1
Sell
-24,873
Closed -$492K 3628
2024
Q4
$492K Buy
24,873
+6,917
+39% +$76.6K ﹤0.01% 2238
2024
Q3
$147K Buy
+17,956
New +$122K ﹤0.01% 2936
2023
Q3
Sell
-6,353
Closed -$49.7K 2983
2023
Q2
$49.7K Buy
+6,353
New +$45.4K ﹤0.01% 2440

Other funds holding MESO

Creative Planning's MESO Position: Q1 2026 in Review

Creative Planning reduced its Mesoblast (MESO) stake by 7.5% in Q1 2026, selling an estimated $16K and leaving 11,800 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

Creative Planning first reported a position in MESO in Q2 2023 and has held it in 7 quarters since. The position peaked at $492K in Q4 2024. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Creative Planning held 11,800 shares of Mesoblast worth $181K as of Q1 2026.
  • Creative Planning sold 959 Mesoblast shares in Q1 2026, an estimated $16K.
  • Mesoblast made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3769 holding.
  • Creative Planning first reported a position in Mesoblast in Q2 2023 and has held it in 7 quarters since.
  • Creative Planning's Mesoblast position peaked at $492K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.